Riskpilot← Back to searchSign inGet full accessMorygis AB
ABActiveOrg 5590909411Dalhemsvägen 143-39General medical practice activities · NACE 8621Est. 20160 employees
Revenue 2025
SEK 258K
+32% vs 2024
EBITDA margin
53.0%
+794% vs 2024
Equity ratio
67.5%
Financial strength
Net profit 2025
SEK 108K
+853% vs 2024
| Revenue | SEK 258K | +32% |
| EBITDA | SEK 137K | +794% |
| Net profit | SEK 108K | +853% |
| Total assets | SEK 344K | +75% |
| Equity | SEK 232K | +88% |
| Employees | 0 | — |
Legal name
Morygis AB
Org number
5590909411
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 december 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska driva rådgivande verksamhet, utbildning och tillhandahålla tjänster inom medicinsk mikrobiologi, framställa fotografiskt material i utbildningssyfte och för försäljning och därmed förenlig verksamhet samt kapitalförvaltning.
Address
Dalhemsvägen 143-39
Email
morygis.ab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 143 | 158 | 188 | 195 | 258 |
| Staff expenses | — | −7 | −2 | −0 | −2 |
| EBITDA | 113 | 40 | 48 | 15 | 137 |
| Depreciation & amort. | −6 | −6 | −6 | — | — |
| EBIT | 107 | 34 | 42 | 15 | 137 |
| Net financials | −1 | −1 | 0 | −1 | −0 |
| Profit before tax | 106 | 33 | 42 | 15 | 137 |
| Tax | −21 | −9 | −9 | −3 | −28 |
| Net profit | 85 | 25 | 33 | 11 | 108 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 291 | 333 | 351 | 197 | 344 |
| Equity | 234 | 79 | 112 | 124 | 232 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 57 | 254 | 239 | 73 | 112 |
| Total debt | 57 | 254 | 239 | 73 | 112 |
EBITDA margin
53.0%
This company
15.8%
Market median
+235% vs market
20212025
Equity ratio
67.5%
This company
38.2%
Market median
+77% vs market
20212025
Return on equity
46.7%
This company
18.4%
Market median
+154% vs market
20212025
Net profit margin
42.0%
This company
8.1%
Market median
+419% vs market
20212025
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20212025
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Morygis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils August Jakob Carper | Deputy Board Member | 0 companies |
| Bengt Erik Svensson | Board of Directors | 0 companies |